• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Psyence Group Inc (OP: PSYGF )

    0.0080 -0.0105 (-56.76%)
    Streaming Delayed Price Updated: 9:55 AM EDT, Oct 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 100,000
    Open 0.0080
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0185
    Today's Range 0.0080 - 0.0080
    52wk Range 0.0080 - 0.0671
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
    Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available. 
    Via Benzinga
    How To Finance A Psychedelics Business? Learn From These Four Companies
    Clearmind Medicine Announces Pricing of $3.5 Million Public Offering 
    Via Benzinga

    Performance

    YTD
    -71.22%
    -71.22%
    1 Month
    -2.44%
    -2.44%
    3 Month
    -26.61%
    -26.61%
    6 Month
    -43.26%
    -43.26%
    1 Year
    -82.10%
    -82.10%

    More News

    Read More
    Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More
    Via Benzinga
    Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio
    Via Benzinga
    Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
    Via Benzinga
    Psychedelics Travel: Clinical-Grade Magic Mushrooms Extract Exported From Southern Africa To UK
    Via Benzinga
    6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
    Via Benzinga
    Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
    Via Benzinga
    Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials
    Via Benzinga
    Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU
    Via Benzinga
    European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed
    Via Benzinga
    International Magic Mushrooms: Where Are They Produced And Where Are They Headed?
    Via Benzinga
    Psyched: Magic Mushrooms Vs. Psychotherapy, Psilocybin For Frontline Health Workers & Protecting Peyote
    Via Benzinga
    Magic Mushrooms Vs. Psychotherapy For Incurable Cancer Diagnosis Moves Forward In UK Clinical Trials
    Via Benzinga
    Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
    Via Benzinga
    Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.